Bay Rivers Group Sells 248 Shares of iShares Biotechnology ETF (NASDAQ:IBB)
Bay Rivers Group trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,759 shares of the financial services provider’s stock after selling 248 shares during the period. […]